Company intelligence / Profile preview

Alcaris Therapeutics

Wayne, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Aclaris Therapeutics is a U.S.-based clinical-stage biopharmaceutical company developing small-molecule and antibody therapies for immuno-inflammatory diseases, with particular strength in dermatology and related immune disorders. Its current pipeline includes bosakitug (ATI-045), an anti-TSLP monoclonal antibody in Phase 2 development for atopic dermatitis, ATI-2138, an oral covalent ITK/JAK3 inhibitor with Phase 2 data in atopic dermatitis, and ATI-052, a bispecific anti-TSLP/anti-IL4R antibody in early clinical development. The company also maintains discovery capabilities in kinase biology through its proprietary KINect platform and operates Confluence Discovery Technologies as a contract research subsidiary. Aclaris is publicly traded on Nasdaq and is headquartered in Wayne, Pennsylvania.

Therapeutic areas: ImmunologyPulmonologyDermatology
Modalities: Monoclonal antibodyBispecific monoclonal antibodySmall molecule
Industry: Biotech

Partnerships

Biosion

Beyond the preview

Go deeper on Alcaris Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcaris Therapeutics.

Explore the full profile